Industry Experts

Sachin Shivatare is a bioconjugation lead at Lilly Oncology in South San Francisco. He earned his Ph.D. in carbohydrate chemistry from National Taiwan University in 2013. He worked for a biotech start-up in Taiwan for six years before joining The Scripps Research Institute in California as a Staff Scientist in 2019. There, he focused on developing PROTACs and site-specific conjugation methodologies for ADCs. In early 2022, he began working on oligonucleotide drug delivery at AMGEN. At Lilly, he supports the oncology ADC pipeline and innovative ADC technology efforts.